A Review on the Use of Gold Nanoparticles in Cancer Treatment

Anticancer Agents Med Chem. 2023;23(20):2171-2182. doi: 10.2174/0118715206268664231004040210.

Abstract

According to a 2020 WHO study, cancer is responsible for one in every six fatalities. One in four patients die due to side effects and intolerance to chemotherapy, making it a leading cause of patient death. Compared to traditional tumor therapy, emerging treatment methods, including immunotherapy, gene therapy, photothermal therapy, and photodynamic therapy, have proven to be more effective. The aim of this review is to highlight the role of gold nanoparticles in advanced cancer treatment. A systematic and extensive literature review was conducted using the Web of Science, PubMed, EMBASE, Google Scholar, NCBI, and various websites. Highly relevant literature from 141 references was chosen for inclusion in this review. Recently, the synergistic benefits of nano therapy and cancer immunotherapy have been shown, which could allow earlier diagnosis, more focused cancer treatment, and improved disease control. Compared to other nanoparticles, the physical and optical characteristics of gold nanoparticles appear to have significantly greater effects on the target. It has a crucial role in acting as a drug carrier, biomarker, anti-angiogenesis agent, diagnostic agent, radiosensitizer, cancer immunotherapy, photodynamic therapy, and photothermal therapy. Gold nanoparticle-based cancer treatments can greatly reduce current drug and chemotherapy dosages.

Keywords: Gold nanoparticles; cancer therapy; diagnosis.; immunotherapy; photodynamic therapy; photothermal therapy.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Gold
  • Humans
  • Metal Nanoparticles* / therapeutic use
  • Nanoparticles*
  • Neoplasms* / diagnosis
  • Neoplasms* / drug therapy
  • Photochemotherapy* / methods
  • Phototherapy

Substances

  • Gold